Form 483

Tarmac Products, Inc. Form 483, 2022-07-22

FDA issued a Form 483 to Tarmac Products, Inc. on 2022-07-22 with 5 public-safe observations.

483· Form 483 issuedHuman Drugs5 observations

Tarmac Products, Inc. · Miami Gardens, United States · Issued July 22, 2022

Overview

  • 5 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

22 Jul 2022
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Joanne E King, Damaris Y Hernandez

22 Jul 2022
21 CFR 211.186(b)(9)

Complete instructions, procedures, specifications et. al.

Cited by Joanne E King, Damaris Y Hernandez

22 Jul 2022
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Joanne E King, Damaris Y Hernandez

22 Jul 2022
21 CFR 211.56(a)

Sanitation--buildings not clean, free of infestation

Cited by Joanne E King, Damaris Y Hernandez

22 Jul 2022
21 CFR 211.58

Buildings not maintained in good state of repair

Cited by Joanne E King, Damaris Y Hernandez

Inspected site

TPTarmac Products, Inc.Miami Gardens, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.186(b)(9)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.56(a)Cited across public-safe Form 483 observations1x
21 CFR 211.58Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 5 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere